Compare CLNE & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CLNE | EOLS |
|---|---|---|
| Founded | 2001 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Natural Gas Distribution | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 500.3M | 454.4M |
| IPO Year | 2006 | 2018 |
| Metric | CLNE | EOLS |
|---|---|---|
| Price | $2.33 | $6.30 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | $3.32 | ★ $15.50 |
| AVG Volume (30 Days) | ★ 2.0M | 796.3K |
| Earning Date | 05-07-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 1.23 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $341,599,000.00 | $297,176,000.00 |
| Revenue This Year | $1.13 | $13.27 |
| Revenue Next Year | $22.65 | $17.62 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 11.61 |
| 52 Week Low | $1.66 | $3.86 |
| 52 Week High | $3.11 | $10.20 |
| Indicator | CLNE | EOLS |
|---|---|---|
| Relative Strength Index (RSI) | 68.75 | 40.64 |
| Support Level | $2.09 | $5.99 |
| Resistance Level | $2.40 | $6.40 |
| Average True Range (ATR) | 0.12 | 0.31 |
| MACD | 0.05 | -0.09 |
| Stochastic Oscillator | 91.10 | 5.34 |
Clean Energy Fuels Corp is a natural gas marketer and retailer operating in the United States and Canada. The company supplies compressed natural gas and liquefied natural gas for the United States (U.S.) and Canadian transportation markets. The majority of revenue is generated within the U.S. and mostly consists of compressed natural gas. The firm operates by purchasing natural gas from local utilities; compressing, cooling, or liquefying it at company-owned plants; and selling natural gas products through company-owned or customer-owned fueling stations. It also builds, operates, and maintains natural gas fueling stations for customers.
Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.